// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Proteomics Reveals Compartment-Specific Alterations in the Extracellular Matrix of Kidney Allografts with Antibody-Mediated Rejection

S. Clotet Freixas - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic antibody mediated rejection

N/A

Recombinant Apoptosis Inhibitor of Macrophage Protein Ameliorates Transplant Ischemia-Reperfusion Injury

J. Y. Lee - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

N/A

Renal Function, Albuminuria, and the Risk of Hemorrhage and Thrombosis after Kidney Transplantation

N. N. Lam - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Results of Litmus (nct 02541916): The Liver Immune Tolerance Bio Marker Utilization Study

A. Chruscinski - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Role of Molecular Microscope in the Interpretation of Endarteritis and Acute Thrombotic Microangiopathy

M. Ciszek - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Thrombotic microangiopathy

N/A

Self-reported Marijuana Use In Kidney Transplant Candidates And Its Association With Access To Transplantation

S. Rodriguez Ramirez - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Serum Apolipoproteins B and A1 Predict the Development of Late Post-Transplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients

R. Malyala - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Post-transplant diabetes mellitus

N/A

Short and Long Term Outcomes of Retrograde vs Antegrade Reperfusion of Liver Transplants. A Propensity Matched Pair Analysis

H. Sharma - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Should First and Second Transplant Candidates Be Treated Equally?

S. Clark - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

N/A

Significantly High FOXP3 mRNA in the Renal Allograft as a Mechanism of Tolerance Induced by Transient Mixed Chimerism in Non-Human Primates

M. Matsunami - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

HDS10 mitochondrial disease

N/A

Soluble C Type Lectin Receptor Protein Inhibition of Natural Killer Cell Mediated Tubular Epithelial Cell Death

S. Balaji - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Steadily Dropping Malignancy Rates after Pediatric Kidney Transplantation Have Now Reversed in the Most Recent Era: A Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)

V. Dharnidharka - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Transplant rejection

N/A

Surgical Site Complications in Kidney Transplant Recipients: Incidence and Outcomes in the Modern Era

J. S. Kim - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Systematic Testing and Specificity Mapping of Alloantigen-Specific Chimeric Antigen Receptors in T Regulatory Cells

C. Lamarche - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Association of Estimated Glomerular Filtration Rate at One Year Post-Kidney Transplant with Graft Loss is Not Modified by Delayed Graft Function

J. Gill - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Delayed graft function

N/A

The Changing Face of T Cell-Mediated Rejection

A. Perkowska-Ptasinska - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Acute cellular rejection

N/A

The Complexity of T Cell-Mediated Rejection Scenarios: Identifying BK in Biopsies with TCMR

P. F. Halloran - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Acute cellular rejection

N/A

The Crucial Role of Molecular Microscope in the Interpretation of Ambiguous Lesions Such as Banff Borderline Changes and Tubulo-Interstitial Inflammation Accompanying PVAN

D. Deborska-Materkowska - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Economic Impact of Surgical Site Infections in Liver Transplantation

Y. Natori - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Evolution of Body Mass Index after Kidney Transplantation in Recipients with a Previous Laparoscopic Sleeve Gastrectomy

G. Chan - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved